Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Massion

Showing results (131-140 of 228) with videos related to

Pageof 23
Sort By:
Thorax|April 8, 2021
Small airway determinants of airflow limitation in chronic obstructive pulmonary diseaseVasiliy V Polosukhin, Sergey S Gutor, Rui-Hong Du, et al.
Proteomics. Clinical Applications|December 8, 2010
MALDI-MS derived prognostic protein markers for resected non-small cell lung cancerBaogang J Xu, Adriana L Gonzalez, Takefumi Kikuchi, et al.
International Journal of Cancer|August 29, 2018
Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancerJonathan M Lehman, Megan D Hoeksema, Jeremy Staub, et al.
International Journal of Cancer|March 31, 2015
Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancerMohamed Hassanein, Jun Qian, Megan D Hoeksema, et al.
Revue Medicale De Liege|October 15, 2019
[Acute respiratory distress syndrome]G Parzibut, J L Canivet, J Guiot, et al.
The Journal of Molecular Diagnostics : JMD|January 14, 2011
A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancerZengliu Su, Dora Dias-Santagata, Markeesa Duke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 12, 2018
Biomarkers in Lung Cancer Screening: Achievements, Promises, and ChallengesLuis M Seijo, Nir Peled, Daniel Ajona, et al.
JAMA|September 24, 2014
Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysisStephen A Deppen, Jeffrey D Blume, Clark D Kensinger, et al.
Cancer Biomarkers : Section a of Disease Markers|May 2, 2022
The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studiesMichael N Kammer, Stephen A Deppen, Sanja Antic, et al.
Plos One|March 16, 2022
18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodulesRafael Paez, Chirayu Shah, Angelina J Cords, et al.
Pageof 23

Showing results (131-140 of 228) with videos related to

Sort By:
Pageof 23
Thorax|April 8, 2021
Small airway determinants of airflow limitation in chronic obstructive pulmonary diseaseVasiliy V Polosukhin, Sergey S Gutor, Rui-Hong Du, et al.
Proteomics. Clinical Applications|December 8, 2010
MALDI-MS derived prognostic protein markers for resected non-small cell lung cancerBaogang J Xu, Adriana L Gonzalez, Takefumi Kikuchi, et al.
International Journal of Cancer|August 29, 2018
Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancerJonathan M Lehman, Megan D Hoeksema, Jeremy Staub, et al.
International Journal of Cancer|March 31, 2015
Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancerMohamed Hassanein, Jun Qian, Megan D Hoeksema, et al.
Revue Medicale De Liege|October 15, 2019
[Acute respiratory distress syndrome]G Parzibut, J L Canivet, J Guiot, et al.
The Journal of Molecular Diagnostics : JMD|January 14, 2011
A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancerZengliu Su, Dora Dias-Santagata, Markeesa Duke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 12, 2018
Biomarkers in Lung Cancer Screening: Achievements, Promises, and ChallengesLuis M Seijo, Nir Peled, Daniel Ajona, et al.
JAMA|September 24, 2014
Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysisStephen A Deppen, Jeffrey D Blume, Clark D Kensinger, et al.
Cancer Biomarkers : Section a of Disease Markers|May 2, 2022
The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studiesMichael N Kammer, Stephen A Deppen, Sanja Antic, et al.
Plos One|March 16, 2022
18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodulesRafael Paez, Chirayu Shah, Angelina J Cords, et al.
Pageof 23